Cellular immune therapy for chronic lymphocytic leukemia.

Abstract:

:Although chemotherapy can induce complete responses in patients with chronic lymphocytic leukemia (CLL), it is not considered curative. Treated patients generally develop recurrent disease requiring additional therapy, which can cause worsening immune dysfunction, myelosuppression, and selection for chemotherapy-resistant leukemia-cell subclones. Cellular immune therapy promises to mitigate these complications and potentially provide for curative treatment. Most experience with this is in the use of allogeneic hematopoietic stem-cell transplantation (allo-HSCT), in which graft-versus-leukemia (GVL) effects can be observed and shown responsible for long-term disease-free survival. However, use of allo-HSCT for CLL is limited because of the lack of suitable donors and the treatment-related morbidity/mortality for elderly patients, who constitute the majority at risk for developing this disease. The GVL effect, however, suggests there are specific CLL-associated antigens that could be targeted in autologous cellular immune therapy. Effective strategies for this will have to overcome the disease-related acquired immune deficiency and the capacity of the leukemia-cell to induce T-cell tolerance, thereby compromising the activity of even conventional vaccines in patients with this disease. We will discuss the different strategies being developed to overcome these limitations that might provide for effective cellular immune therapy of CLL.

journal_name

Blood

journal_title

Blood

authors

Kater AP,van Oers MH,Kipps TJ

doi

10.1182/blood-2007-01-068932

subject

Has Abstract

pub_date

2007-10-15 00:00:00

pages

2811-8

issue

8

eissn

0006-4971

issn

1528-0020

pii

blood-2007-01-068932

journal_volume

110

pub_type

杂志文章,评审

相关文献

BLOOD文献大全
  • Human platelet cytoskeletons: specific content of glycolipids and phospholipids.

    abstract::The lipid composition of platelet cytoskeletons was analyzed. Triton X-100 (0.5%) was used to prepare cytoskeletons from thrombin-treated platelets. The lipid/protein ratio of platelet cytoskeletons was 0.260 and the phospholipid/protein ratio was 0.177, which were comparable to the ratios present in platelets. Howeve...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schick PK,Tuszynski GP,Vander Voort PW

    更新日期:1983-01-01 00:00:00

  • Chronic T cell leukemia with unusual cellular characteristics in ataxia telangiectasia.

    abstract::A 27-year-old male patient with ataxia telangiectasia (AT) developed atypical chronic lymphocytic leukemia with increasing bone marrow infiltration in the absence of organomegaly. One-third of the leukemia cells expressed a mature suppressor/cytotoxic T cell phenotype (T3+ T4- T6- T8+ T10-), two-thirds demonstrated ad...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dührsen U,Uppenkamp M,Uppenkamp I,Becher R,Engelhard M,König E,Meusers P,Meuer S,Brittinger G

    更新日期:1986-08-01 00:00:00

  • Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas.

    abstract::Peripheral T-cell lymphomas (PTCLs) are aggressive tumors in which the current therapy based on multiagent chemotherapy is not successful. Since cytochrome P450 3A subfamily (CYP3A) enzymes are involved in the inactivation of chemotherapy drugs, we hypothesized that CYP3A and P-glycoprotein (MDR1) expression in these ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-02-075036

    authors: Rodríguez-Antona C,Leskelä S,Zajac M,Cuadros M,Alvés J,Moneo MV,Martín C,Cigudosa JC,Carnero A,Robledo M,Benitez J,Martínez-Delgado B

    更新日期:2007-11-01 00:00:00

  • Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.

    abstract::Epigallocatechin-3-gallate (EGCG), a polyphenol extracted from green tea, is an antioxidant with chemopreventive and chemotherapeutic actions. Based on its ability to modulate growth factor-mediated cell proliferation, we evaluated its efficacy in multiple myeloma (MM). EGCG induced both dose- and time-dependent growt...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-022814

    authors: Shammas MA,Neri P,Koley H,Batchu RB,Bertheau RC,Munshi V,Prabhala R,Fulciniti M,Tai YT,Treon SP,Goyal RK,Anderson KC,Munshi NC

    更新日期:2006-10-15 00:00:00

  • Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.

    abstract::Lenalidomide, bortezomib, and dexamethasone (RVd) followed by autologous stem cell transplantation (ASCT) is standard frontline therapy for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM). The addition of daratumumab (D) to RVd (D-RVd) in transplant-eligible NDMM patients was evaluated. Patie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005288

    authors: Voorhees PM,Kaufman JL,Laubach J,Sborov DW,Reeves B,Rodriguez C,Chari A,Silbermann R,Costa LJ,Anderson LD Jr,Nathwani N,Shah N,Efebera YA,Holstein SA,Costello C,Jakubowiak A,Wildes TM,Orlowski RZ,Shain KH,Cowan AJ,

    更新日期:2020-08-20 00:00:00

  • Microvascular abnormalities in sickle cell disease: a computer-assisted intravital microscopy study.

    abstract::The conjunctival microcirculation of 18 homozygous sickle cell disease (SCD) patients during steady-state, painful crisis, and postcrisis conditions was recorded on high-resolution videotapes using intravital microscopy. Selected videotape sequences were subsequently coded, frame-captured, studied, and blindly analyze...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.11.3999

    authors: Cheung AT,Chen PC,Larkin EC,Duong PL,Ramanujam S,Tablin F,Wun T

    更新日期:2002-06-01 00:00:00

  • Studies of factor IX concentrate therapy in hemophilia.

    abstract::The effects of factor IX concentrate therapy on hemostasis in hemophilia patients were studied by means of the radiometric factor IXa assay, the coupled amidolytic assay for factor VIIa, and coagulant assays for factors II, IX, and X, and antithrombin III. Both activated and unactivated concentrates contained factors ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hultin MB

    更新日期:1983-09-01 00:00:00

  • Isolation and characterization of complement receptor type 1 (CR1) storage vesicles from human neutrophils using antibodies to the cytoplasmic tail of CR1.

    abstract::Neutrophil (PMN) activation is associated with increased surface expression of several membrane proteins that are translocated from intracellular pools. Indirect evidence suggests that the intracellular storage pools of complement receptor type 1 (CR1) in resting PMN are distinct from traditional granules and may be t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kumar A,Wetzler E,Berger M

    更新日期:1997-06-15 00:00:00

  • Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development.

    abstract::Mice deficient in c-fms-like tyrosine kinase 3 (FLT3) signaling have reductions in early multipotent and lymphoid progenitors, whereas no evident myeloid phenotype has been reported. However, activating mutations of Flt3 are among the most common genetic events in acute myeloid leukemia and mice harboring internal tan...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-12-258756

    authors: Böiers C,Buza-Vidas N,Jensen CT,Pronk CJ,Kharazi S,Wittmann L,Sitnicka E,Hultquist A,Jacobsen SE

    更新日期:2010-06-17 00:00:00

  • Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1.

    abstract::To investigate the role of peritoneal mesothelial cells in regulating hematopoiesis, as well as inflammation, healing, and tissue regeneration processes, long-term cultures of peritoneal mesothelial cells from human endocavitarian fluids were established. The purity of the cell population was assessed by morphologic a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lanfrancone L,Boraschi D,Ghiara P,Falini B,Grignani F,Peri G,Mantovani A,Pelicci PG

    更新日期:1992-12-01 00:00:00

  • A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation.

    abstract::A novel thrombin inhibitor based on single-stranded (ss) deoxynucleotides with the sequence GGTTGGTGTGGTTGG (thrombin aptamer) has been recently discovered. In this study, we tested its efficacy in inhibiting clot-bound thrombin activity and platelet thrombus formation in an ex vivo whole artery angioplasty model. The...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Li WX,Kaplan AV,Grant GW,Toole JJ,Leung LL

    更新日期:1994-02-01 00:00:00

  • Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation.

    abstract::Severe congenital neutropenia (CN) (Kostmann syndrome) is a hematologic disorder characterized by a maturation arrest of myelopoiesis at the promyelocyte/myelocyte stage of development. This arrest results in severe neutropenia leading to absolute neutrophil counts (ANC) below 0.2 x 10(9)/L associated with severe bact...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Zeidler C,Welte K,Barak Y,Barriga F,Bolyard AA,Boxer L,Cornu G,Cowan MJ,Dale DC,Flood T,Freedman M,Gadner H,Mandel H,O'Reilly RJ,Ramenghi U,Reiter A,Skinner R,Vermylen C,Levine JE

    更新日期:2000-02-15 00:00:00

  • Umbilical cord blood transplantation and cytomegalovirus: Posttransplantation infection and donor screening.

    abstract::This study assessed the incidence of cytomegalovirus (CMV) infection after transplantation of cord blood (CB) from unrelated donors and evaluated strategies for screening CB donors. Posttransplantation CMV infection, reported in 23% of 1221 CB recipients, was associated with patient pretransplantation CMV serology (P ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2006-04-020313

    authors: Albano MS,Taylor P,Pass RF,Scaradavou A,Ciubotariu R,Carrier C,Dobrila L,Rubinstein P,Stevens CE

    更新日期:2006-12-15 00:00:00

  • Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment.

    abstract::In ischemic stroke, treatment options are limited. Therapeutic thrombolysis is restricted to the first few hours after stroke, and the utility of current platelet aggregation inhibitors, including GPIIb/IIIa receptor antagonists, and anticoagulants is counterbalanced by the risk of intracerebral bleeding complications...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2008-04-144758

    authors: Stoll G,Kleinschnitz C,Nieswandt B

    更新日期:2008-11-01 00:00:00

  • An objective sign in painful crisis in sickle cell anemia: the concomitant reduction of high density red cells.

    abstract::The etiopathologic basis of painful crisis in sickle cell anemia is largely unknown, and no objective criteria for its diagnosis and follow-up exist at present. We have studied 11 patients through 14 painful crises and observed a significant decrease of the densest fraction of red cells in 12 of the 14 crises as deter...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fabry ME,Benjamin L,Lawrence C,Nagel RL

    更新日期:1984-08-01 00:00:00

  • How I manage ibrutinib-refractory chronic lymphocytic leukemia.

    abstract::The introduction of the Bruton tyrosine kinase (BTK) inhibitor ibrutinib has dramatically changed the management of chronic lymphocytic leukemia (CLL). Although responses have been durable in the majority of patients, relapses do occur, especially in the high-risk patient population. Most relapses occur as the result ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-09-693598

    authors: Woyach JA

    更新日期:2017-03-09 00:00:00

  • Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.

    abstract::Treatment of human monocytes with vascular endothelial growth factor (VEGF) isolated from tumor cell supernatants was reported to induce monocyte activation and migration. In this study we show that recombinant human VEGF165, and VEGF121 had a maximal effect on human monocyte migration at 65 to 250 pmol/L. Chemotactic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Barleon B,Sozzani S,Zhou D,Weich HA,Mantovani A,Marmé D

    更新日期:1996-04-15 00:00:00

  • Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils.

    abstract::Neutrophil gelatinase-associated lipocalin (NGAL) is a novel 25-kD protein of human neutrophils, that is in part covalently complexed with neutrophil gelatinase. However, both NGAL and gelatinase exist mainly in forms not associated with each other. An explanation for this phenomenon might be that the unassociated pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kjeldsen L,Bainton DF,Sengeløv H,Borregaard N

    更新日期:1994-02-01 00:00:00

  • Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment?

    abstract::Notch signaling pathway regulates many different events of embryonic and adult development; among them, Notch plays an essential role in the onset of hematopoietic stem cells and influences multiple maturation steps of developing lymphoid and myeloid cells. Deregulation of Notch signaling determines several human diso...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-08-376061

    authors: Nwabo Kamdje AH,Krampera M

    更新日期:2011-12-15 00:00:00

  • A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma.

    abstract::Prediagnostic serum concentration of soluble CD30 (sCD30), a marker for chronic B-cell stimulation, has been associated with increased risk of developing AIDS-related non-Hodgkin lymphoma (NHL) in a recent study of HIV(+) patients. To investigate among healthy persons whether serum sCD30 is associated with NHL risk, w...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2009-04-217521

    authors: Purdue MP,Lan Q,Martinez-Maza O,Oken MM,Hocking W,Huang WY,Baris D,Conde B,Rothman N

    更新日期:2009-09-24 00:00:00

  • Retention of B-cell-specific monoclonal antibodies by human lymphoma cells.

    abstract::The rates of endocytosis, intracellular degradation, and cell-surface shedding of 125I-labeled monoclonal antibodies (MoAbs) HD-37 (anti-CD19), B1 (anti-CD20), MB-1 (anti-CD37), BC8 (anti-CD45), and DA4-4 (anti-mu) by B-lymphoma cells were compared by cellular radioimmunoassay, ultrastructural autoradiography, sodium ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Press OW,Howell-Clark J,Anderson S,Bernstein I

    更新日期:1994-03-01 00:00:00

  • Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors.

    abstract::To assess a possible role in tumor progression, the occurrence and type of K- and N-RAS mutations were determined in purified tumor cells, including samples from patients with premalignant monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), and extramedullary plasma cell (PC) tumors (ExPC...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-0833

    authors: Rasmussen T,Kuehl M,Lodahl M,Johnsen HE,Dahl IM

    更新日期:2005-01-01 00:00:00

  • Ibrutinib: a force with a dark side?

    abstract::In this issue of Blood, Martin et al report poor outcomes for ibrutinib-refractory patients with mantle cell lymphoma (MCL). MCL, an uncommon B-cell lymphoma driven by dysregulated cyclin D1, responds well to initial therapy but is destined to relapse. Subsequent single-agent treatments had modest response rates and d...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2016-02-694877

    authors: Smith MR

    更新日期:2016-03-24 00:00:00

  • The proportion of mitoses in different cell lineages changes during short-term culture of normal human bone marrow.

    abstract::To determine the hematopoietic cell lineage of mitotic cells in human bone marrow on direct examination and after 24-hour culture, marrow mitoses from four healthy individuals were studied, using a new technique that allows analysis of karyotypes in cells whose cell membrane and cytoplasm have been preserved. Mitoses ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Keinänen M,Knuutila S,Bloomfield CD,Elonen E,de la Chapelle A

    更新日期:1986-05-01 00:00:00

  • There's no such fool like an immunosenescent fool.

    abstract::In this issue of Blood, Stepensky et al provide an astute description of immunosenescence arising from deficiency in tripeptidyl peptidase II (TPPII). Senescence of T and B lymphocytes is a striking finding, which has recently come into the limelight because it can be linked to primary immunodeficiency syndromes with ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-12-614149

    authors: Seidel MG

    更新日期:2015-01-29 00:00:00

  • Stomatin is a major lipid-raft component of platelet alpha granules.

    abstract::Lipid rafts are detergent-resistant, cholesterol- and sphingolipid-rich membrane domains that are involved in important cellular processes such as signal transduction and intracellular trafficking. Stomatin, a major lipid-raft component of erythrocytes and epithelial cells, is also an abundant platelet protein. Micros...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v100.3.897

    authors: Mairhofer M,Steiner M,Mosgoeller W,Prohaska R,Salzer U

    更新日期:2002-08-01 00:00:00

  • Cirmtuzumab blocks Wnt5a/ROR1 stimulation of NF-κB to repress autocrine STAT3 activation in chronic lymphocytic leukemia.

    abstract::Coculture of nurse-like cells (NLCs) with chronic lymphocytic leukemia (CLL) cells induced leukemia cell phosphorylation of STAT3 (pSTAT3), which could be blocked by anti-Wnt5a antibodies or the anti-ROR1 monoclonal antibody, cirmtuzumab. Time-course studies revealed Wnt5a could induce activation of NF-κB within 30 mi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001366

    authors: Chen Y,Chen L,Yu J,Ghia EM,Choi MY,Zhang L,Zhang S,Sanchez-Lopez E,Widhopf GF 2nd,Messer K,Rassenti LZ,Jamieson C,Kipps TJ

    更新日期:2019-09-26 00:00:00

  • The Hermansky-Pudlak syndrome 1 (HPS1) and HPS2 genes independently contribute to the production and function of platelet dense granules, melanosomes, and lysosomes.

    abstract::Hermansky-Pudlak syndrome (HPS) is an inherited hemorrhagic disease affecting the related subcellular organelles platelet dense granules, lysosomes, and melanosomes. The mouse genes for HPS, pale ear and pearl, orthologous to the human HPS1 and HPS2 (ADTB3A) genes, encode a novel protein of unknown function and the be...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Feng L,Novak EK,Hartnell LM,Bonifacino JS,Collinson LM,Swank RT

    更新日期:2002-03-01 00:00:00

  • Hematopoietic progenitor kinase 1 (HPK1) is required for LFA-1-mediated neutrophil recruitment during the acute inflammatory response.

    abstract::Recruitment of polymorphonuclear neutrophils (PMNs) to sites of acute inflammation critically depends on β2 integrins (CD11/CD18). Recently, the mammalian actin-binding protein 1 (mAbp1) was identified as an important adaptor protein regulating PMN trafficking downstream of β2 integrins. Here, we show that mAbp1 const...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-08-451385

    authors: Jakob SM,Pick R,Brechtefeld D,Nussbaum C,Kiefer F,Sperandio M,Walzog B

    更新日期:2013-05-16 00:00:00

  • Neutralization of tumor necrosis factor activity shortly after the onset of dendritic cell hematopoiesis reveals a novel mechanism for the selective expansion of the CD14-dependent dendritic cell pathway.

    abstract::The CD14-dependent and -independent dendritic cell (DC) pathways are instituted simultaneously when CD34(+) progenitor cells are treated with granulocyte-macrophage colony-stimulating factor (GM-CSF)/tumor necrosis factor (TNF) +/- stem cell factor (SCF) (GTS). If TNF activity is neutralized within 48 hours of cytokin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Santiago-Schwarz F,McCarthy M,Tucci J,Carsons SE

    更新日期:1998-08-01 00:00:00